JAK2 and essential thrombocythemia: Besides, when considering platelet parameters, most studies focused on thrombopenia, there has been only one study [23] exploring the relationship between JAK2 V617F mutation and platelet parameters in ET patients, including platelet distribution width (PDW) and mean platelet volume (MPV).